on M2Care
M2Care Secures €26 Million to Boost Healthtech Innovations
Paris, 3 September 2025 – M2care, a European Healthtech venture studio, announced the successful closure of a €26 million fundraising round. This round included a new institutional investor, the French Tech Acceleration 2 fund (FTA2), managed by Bpifrance. The funds aim to accelerate the creation and development of eight innovative healthcare projects.
M2care collaborates with early-stage ventures in healthcare, bridging academia, investors, and industry. The studio is advancing projects in cardiology, dermatology, ophthalmology, and neurology. Current investments include Previa Medical, TheraSonic, and Rhovica Neuroimaging, each focusing on innovative medical devices.
The involvement of FTA2, as part of France 2030, underscores M2care's commitment to pioneering healthcare advancements. The backing from Bpifrance reinforces efforts to enhance public health through technological innovation.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all M2Care news